Oxytocin Injection

[16 March 2015]

Products Affected - Description

Oxytocin 10 unit/mL, Fresenius Kabi, USA
1 mL vial, 25 count (NDC 63323-0012-01)
10 mL vial, 25 count (NDC 63323-0012-10)
30 mL vial, 10 count (NDC 63323-0012-30) 
Oxytocin 10 unit/mL, West-Ward
1 mL vial, 25 count (NDC 00641-6114-25)
10 mL vial, 25 count (NDC 00641-6115-25)

Pitocin 10 unit/mL, Par Sterile Products (formerly JHP)
1 mL vial, 25 count (NDC 42023-0116-25)

Reason for the Shortage

  • Fresenius Kabi, USA (formerly APP) states the shortage is due to increased demand.
  • Par Sterile Products (formerly JHP) discontinued generic oxytocin injection in July 2014.
  • West-Ward cannot provide a reason for the shortage. 

Available Products

Pitocin 10 unit/mL, Par Sterile Products (formerly JHP)
10 mL vial, 1 count (NDC 42023-0116-01)
10 mL vial, 25 count (NDC 42023-0116-02)
50 mL bulk vial, 1 count (NDC 42023-0130-06)

Estimated Resupply Dates

  • Fresenius has oxytocin 10 units/mL 10 mL vials on intermittent back order and the company is releasing product as it becomes available. Oxytocin 1 mL vials are on allocation. Oxytocin 30 mL vials are available with short expiration dating (< 7 months).
  • West-Ward has oxytocin 10 units/mL 1 mL and 10 mL vials on back order and the company cannot estimate a release date.
  • Par Sterile Products has Pitocin 1 mL vials on back order and the company estimates a release date in mid-March 2015.

Related Shortages


March 16, February 11 and 25, January 7 and 16, 2015; December 1 and 18, October 20, September 9 and 18, August 6, July 18, June 12, May 5 and 27, April 3, March 6 and 27, February 6, January 24, 2014; December 4 and 18, November 14 and 27, October 15 and 30, August 13, July 2 and 23, June 19, April 26, March 15 and 29, February 27, January 16 and 30, 2013; December 14, November 16, September 24, August 10 and 23, June 15, May 7 and 17, April 10 and 27, March 9 and 23, February 10 and 23, 2012; December 22, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT. 


This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.